Patents by Inventor Rikard Reneland

Rikard Reneland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR IDENTIFYING RISK OF BREAST CANCER AND TREATMENTS THEREOF
    Publication number: 20090317816
    Abstract: Provided herein are methods for identifying risk of breast cancer in a subject and/or a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Application
    Filed: March 9, 2009
    Publication date: December 24, 2009
    Applicant: Sequenom, Inc.
    Inventors: Richard B. Roth, Matthew Roberts Nelson, Stefan M. Kammerer, Andreas Braun, Rikard Reneland
  • METHODS FOR IDENTIFYING RISK OF BREAST CANCER AND TREATMENTS THEREOF
    Publication number: 20090258344
    Abstract: Provided herein are methods for identifying risk of breast cancer in a subject and/or a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Application
    Filed: May 27, 2004
    Publication date: October 15, 2009
    Applicant: SEQUENOM, INC.
    Inventors: Richard B. Roth, Matthew Roberts Nelson, Andreas Braun, Stefan M. Kammerer, Mikhail F. Denissenko, Rikard Reneland, Caridad Rosette, Carolyn R. Hoyal-Wrightson
  • Methods for identifying risk of breast cancer and treatments thereof
    Patent number: 7510835
    Abstract: Provided herein are methods for identifying risk of breast cancer in a subject and/or a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Grant
    Filed: November 25, 2003
    Date of Patent: March 31, 2009
    Assignee: Sequenom, Inc.
    Inventors: Richard B. Roth, Matthew Roberts Nelson, Stefan M. Kammerer, Andreas Braun, Rikard Reneland
  • Methods for Identifying Risk of Low Bmd and Treatments Thereof
    Publication number: 20070292849
    Abstract: Provided herein are methods for identifying a risk of low BMD in a subject, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating low BMD-related disorders, such as osteoporosis, and therapeutic and preventative methods applicable to osteoporosis. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Application
    Filed: December 29, 2005
    Publication date: December 20, 2007
    Inventors: Steven Mah, Carolyn Hoyal-Wrightson, Stefan Kammerer, Matthew Nelson, Andreas Braun, Rikard Reneland
  • Methods for identifying risk of breast cancer and treatments thereof
    Publication number: 20060204967
    Abstract: Provided herein are methods for identifying risk of breast cancer in a subject and/or a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Application
    Filed: November 25, 2003
    Publication date: September 14, 2006
    Inventors: Richard Roth, Andreas Braun, Stefan Kammerer, Matthew Nelson, Rikard Reneland
  • Methods for identifying risk of breast cancer and treatments thereof
    Publication number: 20050272043
    Abstract: Provided herein are methods for identifying risk of breast cancer in a subject and/or a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Application
    Filed: May 27, 2004
    Publication date: December 8, 2005
    Inventors: Richard Roth, Andreas Braun, Stefan Kammerer, Matthew Nelson, Rikard Reneland, Carolyn Hoyal-Wrightson
  • Methods for identifying risk of breast cancer and treatments thereof
    Publication number: 20050214771
    Abstract: Provided herein are methods for identifying risk of breast cancer in a subject and/or a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Application
    Filed: November 25, 2003
    Publication date: September 29, 2005
    Inventors: Richard Roth, Andreas Braun, Stefan Kammerer, Matthew Nelson, Rikard Reneland
  • Methods for identifying risk of breast cancer and treatments thereof
    Publication number: 20050192239
    Abstract: Provided herein are methods for identifying risk of breast cancer in a subject and/or a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Application
    Filed: November 25, 2003
    Publication date: September 1, 2005
    Inventors: Richard Roth, Matthew Nelson, Stefan Kammerer, Andreas Braun, Rikard Reneland
  • Methods for identifying risk of breast cancer and treatments thereof
    Publication number: 20050118606
    Abstract: Provided herein are methods for identifying a risk of cancer in a subject and/or a subject at risk of cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating cancer, and therapeutic methods for treating cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in a KLF12 nucleic acid, which has a nucleotide sequence exemplified in SEQ ID NO: 1, 2 or 3.
    Type: Application
    Filed: November 25, 2003
    Publication date: June 2, 2005
    Inventors: Richard Roth, Caridad Rosette, Mikhail Denissenko, Matthew Nelson, Rikard Reneland, Andreas Braun, Stefan Kammerer
  • Methods for identifying risk of breast cancer and treatments thereof
    Publication number: 20050064442
    Abstract: Provided herein are methods for identifying a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Application
    Filed: November 25, 2003
    Publication date: March 24, 2005
    Inventors: Richard Roth, Josephine Atienza, Mikhail Denissenko, Andreas Braun, Stefan Kammerer, Matthew Nelson, Rikard Reneland
  • Methods for identifying risk of breast cancer and treatments thereof
    Publication number: 20050053958
    Abstract: Provided herein are methods for identifying risk of breast cancer in a subject and/or a subject at risk of breast cancer, reagents and kits for carrying out the methods, methods for identifying candidate therapeutics for treating breast cancer, and therapeutic methods for treating breast cancer in a subject. These embodiments are based upon an analysis of polymorphic variations in nucleotide sequences within the human genome.
    Type: Application
    Filed: November 25, 2003
    Publication date: March 10, 2005
    Inventors: Richard Roth, Matthew Nelson, Stefan Kammerer, Andreas Braun, Rikard Reneland